PT1275638E - Preparado de combinacao para a terapia de doencas imunologicas - Google Patents

Preparado de combinacao para a terapia de doencas imunologicas

Info

Publication number
PT1275638E
PT1275638E PT02013275T PT02013275T PT1275638E PT 1275638 E PT1275638 E PT 1275638E PT 02013275 T PT02013275 T PT 02013275T PT 02013275 T PT02013275 T PT 02013275T PT 1275638 E PT1275638 E PT 1275638E
Authority
PT
Portugal
Prior art keywords
preparation
therapy
combination
immunological diseases
biosynthesis inhibitor
Prior art date
Application number
PT02013275T
Other languages
English (en)
Inventor
Juergen Dr Lindner
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of PT1275638E publication Critical patent/PT1275638E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Mycology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT02013275T 2001-07-06 2002-06-18 Preparado de combinacao para a terapia de doencas imunologicas PT1275638E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10132308A DE10132308A1 (de) 2001-07-06 2001-07-06 Kombinationspräparat zur Therapie von immunologischen Erkrankungen

Publications (1)

Publication Number Publication Date
PT1275638E true PT1275638E (pt) 2006-09-29

Family

ID=7690511

Family Applications (1)

Application Number Title Priority Date Filing Date
PT02013275T PT1275638E (pt) 2001-07-06 2002-06-18 Preparado de combinacao para a terapia de doencas imunologicas

Country Status (10)

Country Link
US (1) US20030017166A1 (pt)
EP (1) EP1275638B1 (pt)
JP (1) JP2003063995A (pt)
KR (1) KR20030005042A (pt)
AT (1) ATE329898T1 (pt)
CA (1) CA2392187A1 (pt)
DE (2) DE10132308A1 (pt)
DK (1) DK1275638T3 (pt)
ES (1) ES2265007T3 (pt)
PT (1) PT1275638E (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2598668A1 (en) * 2005-02-25 2006-09-08 Mutual Pharmaceutical Company, Inc. Dosage forms of antibiotics and combinations of antibiotics and symptomatic relief agents
EP2183241B1 (en) 2007-05-03 2012-12-19 Pfizer Limited 2-pyridine carboxamide derivatives as sodium channel modulators
JP6173886B2 (ja) * 2012-11-21 2017-08-02 東芝メディカルシステムズ株式会社 超音波診断装置、画像処理装置及び画像処理方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL186239B (nl) * 1975-06-05 Hoechst Ag Werkwijze voor de bereiding van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor de bereiding van een 2-hydroxyethylideencyaanazijnzuuranilide geschikt voor toepassing bij deze werkwijze.
US4565696A (en) * 1983-08-03 1986-01-21 The Regents Of The University Of California Production of immunogens by antigen conjugation to liposomes
ATE339451T1 (de) * 1992-07-09 2006-10-15 Novartis Vaccines & Diagnostic Antagonistische monoklonale antikörper gegen menschliches cd40
US5747034A (en) * 1992-07-09 1998-05-05 Chiron Corporation Methods and materials for the induction of T cell anergy
JPH06298654A (ja) * 1993-04-12 1994-10-25 Sumitomo Electric Ind Ltd 抗原特異的免疫抑制剤
AU3980595A (en) * 1994-11-10 1996-06-06 Cellena (Cell Engineering) A.G. Composition containing pooled transferrins as an active principle for the induction of immune tolerance against antigens
DE69532557T2 (de) * 1995-07-20 2004-12-23 Cellena (Cell Engineering) Ag Zubereitung enthaltend Glykane übereinstimmend mit Transferrin Glykaner als aktives Prinzip für die Induktion der Immuntoleranz gegen Antigene
AU5696198A (en) * 1996-12-06 1998-06-29 Amgen, Inc. Combination therapy using a tnf binding protein for treating tnf-mediated diseases
ES2312179T3 (es) * 1996-12-06 2009-02-16 Amgen Inc. Terapia combinada que utiliza un inhibidor del il-1 para el tratamiento de enfermedades mediadas por el il-1.
US5935577A (en) * 1998-01-23 1999-08-10 Autoimmune Inc. Treatment of autoimmune disease using tolerization in combination with methotrexate

Also Published As

Publication number Publication date
DE10132308A1 (de) 2003-01-30
KR20030005042A (ko) 2003-01-15
ES2265007T3 (es) 2007-02-01
DE50207168D1 (de) 2006-07-27
US20030017166A1 (en) 2003-01-23
CA2392187A1 (en) 2003-01-06
EP1275638B1 (de) 2006-06-14
JP2003063995A (ja) 2003-03-05
DK1275638T3 (da) 2006-10-16
ATE329898T1 (de) 2006-07-15
EP1275638A1 (de) 2003-01-15

Similar Documents

Publication Publication Date Title
WO2004007743A3 (en) Use of cpg nucleic acids in prion-disease
DE69532760D1 (de) Mittel zur verabreichung von antigenen
AU2002310187A1 (en) Inhibitors of protein kinase for the treatment of disease
ATE360706T1 (de) Peptidakzeptor ligationsverfahren
EP1352897A3 (en) Adamantane derivatives for the treatment of inflammatory, immune and cardiovascular diseases
CY1108101T1 (el) Ενωσεις πυριμιδινης και η χρηση τους στην παρασκευη ενος τριαζολο-πυριμιδιν καρβα νουκλεοζιτη
ECSP045520A (es) Metodos de tratamiento con inhibidores de la ptec y agentes antihipertensivos
IL163812A (en) Immunizing composition, antigenic product and isolated antigenic peptide for inducing an immune response against beta-secretase cleavage site of amyloid the precursor protein
WO2003104425A3 (en) NEW STABLE ANTI-CD22 ANTIBODIES
AU2002317172A1 (en) Tools for the diagnosis, molecular definition and development of treatment of chronic inflammatory joint diseases
WO2002096348A3 (fr) Produit comprenant du mikanolide ou du dihydromikanolide en association avec un autre agent anti-cancereux
WO2002074812A3 (en) Antibodies for preventing and treating attaching and effacing escherichia coli (aeec) associated diseases
PT1275638E (pt) Preparado de combinacao para a terapia de doencas imunologicas
EP1364657A4 (en) REMEDIES AGAINST TUMORS AFFECTING HEMATOPOIETIC BODIES
WO2003094957A3 (en) Methods of therapy for inducing tolerance
UA83989C2 (ru) Выделенный пептид, который стимулирует противоопухолевый иммунный ответ, фармацевтическая композиция на его основе и ее применение
AU2002256775A1 (en) Therapeutic method for inducing tolerance
WO2000027429A3 (en) Vaccine against papillomatous digital dermatitis (pdd)
WO2001053339A3 (en) Egg specific surface proteins
IT1295776B1 (it) Sistema di azionamento elettromeccanico dei pressori negli strettoi per il montaggio dei mobili.
WO2003002066A3 (en) Glycosylated kinamycins and methods of making and using them
AU2002308275A1 (en) Protein having multiple antigen/epitope sequences and being immobilized for the diagnosis of hiv infections
ITMI20010760A0 (it) Associazione di enzimi coadiuvante nella terapia con interferone
DE60233819D1 (de) Doppelester
ITPN20020071A1 (it) Procedimento per la fabbricazione di mobili.